EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The impact of tRNA modifications on translation in cancer: identifying novel therapeutic avenues

Ana M Añazco-Guenkova, Borja Miguel-López, Óscar Monteagudo-García, Raquel García-Vílchez, Sandra Blanco iD

NAR Cancer · 2024

DOI: 10.1093/narcan/zcae012 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift NAR Cancer, 2024. Verfasst von Ana M Añazco-Guenkova und 4 weiteren Autor:innen. Beteiligte Einrichtung: Centro de Investigación del Cáncer and Instituto de Biología Molecular y Celular del Cáncer, Consejo Superior de Investigaciones Científicas (CSIC) -…. Hauptthemen laut MEDLINE: Neoplasms, RNA, Transfer, Protein Biosynthesis, RNA Processing, Post-Transcriptional. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 197 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Spanish Ministry of Science and Innovation, European Regional Development Fund, European Social Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recent advancements have illuminated the critical role of RNA modifications in post-transcriptional regulation, shaping the landscape of gene expression. This review explores how tRNA modifications emerge as critical players, fine-tuning functionalities that not only maintain the fidelity of protein synthesis but also dictate gene expression and translation profiles. Highlighting their dysregulation as a common denominator in various cancers, we systematically investigate the intersection of both cytosolic and mitochondrial tRNA modifications with cancer biology. These modifications impact key processes such as cell proliferation, tumorigenesis, migration, metastasis, bioenergetics and the modulation of the tumor immune microenvironment. The recurrence of altered tRNA modification patterns across different cancer types underscores their significance in cancer development, proposing them as potential biomarkers and as actionable targets to disrupt tumorigenic processes, offering new avenues for precision medicine in the battle against cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsRNA, TransferProtein BiosynthesisRNA Processing, Post-TranscriptionalHumansGene Expression Regulation, NeoplasticAnimalsTumor Microenvironment

Substanzen

RNA, Transfer

Autor:innen und Institutionen

  • Centro de Investigación del Cáncer and Instituto de Biología Molecular y Celular del Cáncer, Consejo Superior de Investigaciones Científicas (CSIC) - University of Salamanca, 37007 Salamanca, Spain.
  • Instituto de Investigación Biomédica de Salamanca (IBSAL), Hospital Universitario de Salamanca, 37007 Salamanca, Spain.

ORCID-Profile: Sandra Blanco

Förderung

  • Spanish Ministry of Science and Innovation
  • European Regional Development Fund
  • European Social Fund
  • USAL-Santander
  • Junta de Castilla y León and Fondo Social Europeo

Zitieren

APA

Añazco-Guenkova, A. M., Miguel-López, B., Monteagudo-García, Ó., García-Vílchez, R., & Blanco, S. (2024). The impact of tRNA modifications on translation in cancer: identifying novel therapeutic avenues. NAR Cancer. https://doi.org/10.1093/narcan/zcae012

Vancouver

Añazco-Guenkova AM, Miguel-López B, Monteagudo-García Ó, García-Vílchez R, Blanco S. The impact of tRNA modifications on translation in cancer: identifying novel therapeutic avenues. NAR Cancer. 2024. doi:10.1093/narcan/zcae012

BibTeX
@article{AazcoGuenkova2024,
  author = {Añazco-Guenkova, Ana M and Miguel-López, Borja and Monteagudo-García, Óscar and García-Vílchez, Raquel and Blanco, Sandra},
  title = {The impact of tRNA modifications on translation in cancer: identifying novel therapeutic avenues},
  journal = {NAR Cancer},
  year = {2024},
  doi = {10.1093/narcan/zcae012}
}
Kostenlos starten →